India has long been known as the “pharmacy of the world” for supplying affordable generic drugs and vaccines. But the country achieved a major milestone in pharmaceutical innovation last year: Nafithromycin (brand name Miqnaf), developed by India's Wockhardt with support from the Biotechnology Industry Research Assistance Council (BIRAC). This is...